(Q52576369)

3 May 2018

title

Survey of patients after discontinuing venom immunotherapy. (English)

1 reference

3 May 2018

1 reference

Lawrence M. Lichtenstein

series ordinal

3

object named as

Lichtenstein LM

1 reference

3 May 2018

Anne Kagey-Sobotka

series ordinal

2

object named as

Kagey-Sobotka A

1 reference

3 May 2018

author name string

Golden DB

series ordinal

1

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

3 May 2018

number of pages

6

1 reference

The Journal of Allergy and Clinical Immunology

inferred from page(s)

published in

1 reference

3 May 2018

volume

105

1 reference

3 May 2018

issue

2 Pt 1

1 reference

3 May 2018

page(s)

385-390

1 reference

3 May 2018

Guidelines for venom immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Prospective observations on stopping prolonged venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Discontinuing venom immunotherapy: outcome after five years.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Discontinuing venom immunotherapy: extended observations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Venom immunotherapy: when is it reasonable to stop.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Epidemiology of Insect Venom Sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Natural history of Hymenoptera venom sensitivity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Clinical and immunologic observations in patients who stop venom immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Clinical and immunologic follow-up of patients who stop venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Treatment Failures With Whole-Body Extract Therapy of Insect Sting Allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2800%2990092-7

7 January 2021

10.1016/S0091-6749(00)90092-7

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018